close

Products

Date: 2012-01-09

Type of information:

Product name: Corifact®

Compound: Factor XIII Concentrate made from the pooled plasma of healthy donors

Therapeutic area:

Action mechanism: substitution therapy

Company: CSL Behring (USA)

Disease: congenital Factor XIII deficiency

Latest news:

Patents:

Submission of marketing authorization application USA :

Submission of marketing authorization application UE:

Withdrawal of marketing authorization application USA:

Withdrawal of marketing authorization application UE:

US authorization: 2011-02-18

UE authorization:

Favourable opinion UE:

Favourable opinion USA:

Orphan status USA:

Orphan status UE:

Pediatric exclusivit _USA:

Pediatric exclusivity UE:

OTC status:

Other news:

Is general: Yes